📰 Preclinical Development News
Page 7 - Preclinical Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Preclinical Development. Real-time updates on events, politics, business and more.
March 23, 2023
/PRNewswire/ -- The "Clinical Trials Outsourcing Market Share, Size, Trends, Industry Analysis Report, By End-Use, By Therapeutics Area, By Workflow, By...
March 14, 2023
Thursday April 6, 2023, at 8am EDT, 2pm CEST Regulatory News: Sensorion, (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company, specialising in the development of novel therapies
March 2, 2023
Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Investor and Scientific Conferences in March 02.03.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate in Investor and Scientific Conferences in March NEW YOR...
March 2, 2023
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...
March 1, 2023
Dublin, March 01, 2023 (GLOBE NEWSWIRE) -- The "Clinical Trials Outsourcing Market Share, Size, Trends, Industry Analysis Report, By End-Use, By...
February 20, 2023
/PRNewswire/ -- Eurocine Vaccines ("Eurocine" or the "Company") announces today that the Companys Director of Preclinical Development, Dr. Karl Ljungberg, has...
February 17, 2023
/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that three oral and eight poster presentations will be presented at the 19th Annual...
February 16, 2023
Yorba Linda, CA (PRWEB) February 16, 2023 -- Yorba Linda, CA (February 16, 2023) - Labroots, the leading scientific social networking website offering
February 10, 2023
/PRNewswire/ -- The "Microbiome Therapeutics: Global Markets" report has been added to ResearchAndMarkets.coms offering. The global Microbiome Therapeutics...
February 2, 2023
Regulatory News: Sensorion (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the